CN101940700A - Dai nationality medicine for treating rheumatism - Google Patents

Dai nationality medicine for treating rheumatism Download PDF

Info

Publication number
CN101940700A
CN101940700A CN 201010292539 CN201010292539A CN101940700A CN 101940700 A CN101940700 A CN 101940700A CN 201010292539 CN201010292539 CN 201010292539 CN 201010292539 A CN201010292539 A CN 201010292539A CN 101940700 A CN101940700 A CN 101940700A
Authority
CN
China
Prior art keywords
parts
medicine
powder
dai nationality
reach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201010292539
Other languages
Chinese (zh)
Other versions
CN101940700B (en
Inventor
桂兰仙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102925390A priority Critical patent/CN101940700B/en
Publication of CN101940700A publication Critical patent/CN101940700A/en
Application granted granted Critical
Publication of CN101940700B publication Critical patent/CN101940700B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to Dai nationality medicine for treating rheumatism, which is powder or capsules formed by mixing the following raw materials in parts by weight, or tablets or capsules obtained in a boiling way from mixture: 0.1 to 0.5 part of erythrina indica lam, 1 to 2 parts of sargentgloryvine stem, 0.5 to 1.5 parts of gynostemma pentaphylla, 1 to 2 parts of root of panax notoginseng, 0.2 to 1 part of Aristolochia delavayi, 0.2 to 1 part of Maytenus hookeri, 0.1 to 0.9 part of Paris polyphylla, 1 to 2 parts of Purple dangshen, 1 to 2 parts of spicy root, and 4 to 8 parts of kusnezoff monkshood root, wherein the fineness of the powder is generally not less than 120 meshes, and the powder can be directly taken by boiling water. The Dai nationality medicine is characterized by having fast effect to rheumatic diseases, such as stubborn rheumatoid arthritis. When the medicine is continuously taken for a week, swelling fades away, and pain sharply reduces. The effective rate of the medicine can reach 95%, and the recovery rate can reach 30%. For tumours, such as myoma of uterus and on the like, the effective rate of the medicine can reach 85%, and the recovery rate can reach 30%. In addition, the medicine also has obvious curative effect to the diseases, such as lumbar hyperosteogeny, knee bone hyperplasia, general waist ache, scapulohumeral periarthritis, sciatica and on the like.

Description

The Dai nationality's rheumatism medicine among the people
Technical field
The invention belongs to a kind of the Dai nationality rheumatism medicine among the people.
Background technology
Dai Nationality's medicine is exactly the Dai nationality's folk tradition medicine, is an ingredient of Chinese medicine, but Dai Nationality's medicine, the Dai Nationality particularly among the people medicine is compared nationality and the local characteristics with himself with traditional Chinese medicine.Dai Nationality's medicine is one of ancient traditional medicine of China, and is just on the books in " pattra leaves warp " before 2500.Xishuangbanna, Yunnan, the Dai nationality ancestral home, local superior natural conditions provide ideal medicine resource for Dai Nationality's medicine, and according to statistics, China the Dai nationality medicine has 1200 kinds." Xishuangbanna Dai Nationality medicine will " has recorded 520 kinds, and wherein the most frequently used has 71 kinds.Some the Dai nationality prescription of passing on from generation to generation among the people is to some sick painful unique curative effect that has.It is significant to excavate, put in order, improve the doctor of the medicine Dai Nationality of the Dai Nationality.
Aspect diseases such as treatment rheumatic arthritis, tumor, many original proved recipes are arranged in Dai Nationality's medicine, curative effect is fairly obvious.But these proved recipes are family passes on from generation to generation, and does not closely leak, and is unfavorable for the succession and the development of the medicine of national minorities.
Summary of the invention
Purpose of the present invention proposes a kind of the Dai nationality rheumatism medicine among the people exactly, and this medicine has characteristics such as detumescence is fast, rapid, the difficult recurrence of unstinging to rheumatic arthritis, lipoma under hysteromyoma, the spleen is also had obvious curative effects, and this medicine compatibility is reasonable, taking convenience, the medicine source is easy to get, low production cost.
This Dai nationality rheumatism medicine among the people that the present invention proposes is characterized in that it is powder or the capsule that is mixed by following former medicine proportioning by weight; The perhaps tablet or the capsule that obtain to boil the mode of putting forward of mixture:
Cortex erythrinae 0.1-0.5 part; Caulis Sargentodoxae 1-2 part; Herb Gynostemmae Pentaphylli 0.5-1.5 part; Radix Notoginseng 1-2 part; Mountain Fructus Tsaoko 0.2-1 part; Folium Mayteni hookeri 0.2-1 part; Rhizoma Paridis 0.1-0.9 part; Purple Radix Codonopsis 1-2 part; Armoracia rusticana (Lam.) P. Gaertner et Sc 1-2 part; Radix Aconiti Kusnezoffii 4-8 part.
In the said ratio scope, be good with following proportioning again:
0.3 part of Cortex erythrinae; 1.5 parts of Caulis Sargentodoxae; 1.1 parts of Herb Gynostemmae Pentaphylli; 1.5 parts of Radix Notoginsengs; 0.6 part of mountain Fructus Tsaoko; 0.6 part of Folium Mayteni hookeri; 0.5 part of Rhizoma Paridis; 1.6 parts of purple Radix Codonopsis; 1.2 parts of Armoracia rusticana (Lam.) P. Gaertner et Sc; 6.1 parts of Radix Aconiti Kusnezoffii.
The above-mentioned former medicine weight of respectively distinguishing the flavor of refers to dry weight, and the medicine attitude refers to the former medicine under the shop of Chinese medicines sale state.
The fineness of powder generally is not less than 120 orders (0.12mm).
The powder of this medicine can directly take with boiled water.Each 3-6g that is grown up, day clothes three times.Taboo: it is cold that period in a medicine is kept away acid.
Characteristics of the present invention are that to rheumatism rapid-action as obstinate rheumatic arthritis, in one week of continuous use, swelling is disappeared, and pain falls sharply, and effective percentage reaches 95%, and cure rate reaches 30%.To tumors such as hysteromyoma, continuous use 15 days, it is original 1/3rd that tumor narrows down to, and effective percentage reaches 85%, and cure rate is up to 30%.
In addition, diseases such as lumbar vertebra hyperosteogeny, knee joint hyperosteogeny, general waist and leg ache, scapulohumeral periarthritis, sciatica also there is obvious curative effects.
Further specify positive beneficial effect of the present invention with example below.
The specific embodiment
Example 1, what so-and-so, the woman, 70 years old, Han nationality, Xin Ansuo town, Mengzi, Yunnan peasant suffers from lumbar vertebra hyperosteogeny and prolapse of lumbar intervertebral disc more than a year, the long-term pain of patient unbearably, the waist activity is seriously limited, difficulty in walking, medication is countless, DeGrain.Change clothes drug powder of the present invention between in July, 2009, serve on a week, pain obviously alleviates, and the swelling of waist bottom disappears, and walking freely.Obey January, symptom disappears entirely again.
These routine powder flavour of a drug are composed as follows:
0.3 part of Cortex erythrinae; 1.5 parts of Caulis Sargentodoxae; 1.1 parts of Herb Gynostemmae Pentaphylli; 1.5 parts of Radix Notoginsengs; 0.6 part of mountain Fructus Tsaoko; 0.6 part of Folium Mayteni hookeri; 0.5 part of Rhizoma Paridis; 1.6 parts of purple Radix Codonopsis; 1.2 parts of Armoracia rusticana (Lam.) P. Gaertner et Sc; 6.1 parts of Radix Aconiti Kusnezoffii.
Usage and dosage: boiled water takes, day clothes three times, each 5g.All the other are the same.
Example 2, Zhao so-and-so, the man, 60 years old, Han nationality, Linan town, Jianshui County, Yunnan Province retired worker suffers from rheumatic arthritis for a long time, two knee joint enlargements have an intense pain, traveling be unable to do without crutch, uses many Western medicine, has little effect.At the beginning of 2009 7 months, use powder treatment of the present invention instead through friend's introduction, continuous use is after one month, and the swelling of joint is disappeared as usual, and pain subtracts greatly.After continuing to take another month, the pain complete obiteration.After this do not see recurrence, have no adverse reaction yet.Patient and family members are all very satisfied.
These routine flavour of a drug are formed, the same example of usage and dosage.
Example 3, the king so-and-so, man 65 years old, Tonghai County, Yunnan peasant suffers from lumbar vertebra hyperosteogeny companion annuler bulge, flank pain, foot acid lower limb is soft, difficulty in walking is weak unable.The long-term crutch that relies on is walked.Begin to take powder of the present invention January calendar year 2001, medication took effect after ten days, and patient's private prosecution disease and pain are all greatly alleviated.After this serve on 90 days again, pain disappears entirely, and walking freely.So far do not send out.This routine flavour of a drug composition, usage and dosage are all with example 1.
Example 4, the rock village, the man, 53 years old, the Dai nationality, Jinghong City, Yunnan peasant suffers from brothers' arthralgia for a long time.Take powder of the present invention in March, 2008, pain fell sharply in seven days, recovery from illness after three months.This routine flavour of a drug composition, usage and dosage are with example 1.
Example 5, the king so-and-so, the man, the Dai nationality, Jinghong, Yunnan farm worker suffers from sciatica, the state of an illness was just controlled in medication in seven days, after 15 days, the ailing disappearance.This routine flavour of a drug composition, usage and dosage are with example 1.
Example 6, beautiful so-and-so, the woman, 56 years old, the Dai nationality, river mouth, Yunnan county inhabitant of a border area suffers from lipoma under the spleen.Check to hospital after 15 days with the powder treatment with example 1, tumor is obviously dwindled, and medication is the tumor disappearance after three months.Usage and dosage is with example 1.
Example 7, beautiful certain, woman 26 years old, the Dai nationality, the big graceful peasant of stockaded village in Jinghong City, Yunnan suffers from hysteromyoma, the big 4cm of tumor piece uses the powder treatment with example 1, tumor narrows down to originally 1/3rd after 15 days, to examination in hospital, muscular tumor disappears after one month in medication again, recovery from illness.Usage and dosage is with example 1.
Above case is removed the 4-7 exception, is the clinical case of military subarea, Yunnan hospital.In addition, this medicine powder suffers from rheumatic arthritis, lumbar vertebra hyperosteogeny in this military subarea hospital to 156 examples, the patient of knee joint hyperosteogeny has carried out clinical practice, wherein the male patient accounts for approximately 2/3rds, and female patient accounts for 1/3rd, and age 40-70 year is not waited.Total drug effect situation is: this one week of powder medication takes effect, the most private prosecution pain relief of patient, and drug effect is obvious.Total effective percentage reaches 95%, cure rate 30%.
This minute, district hospital was at part patient's concrete condition, flavour of a drug formed carried out certain adjustment.Total situation is: when the proportioning of each flavour of a drug changed in interval range separately, pharmacodynamic change was not too obvious, all was effective.

Claims (3)

1. the Dai nationality's rheumatism medicine among the people is characterized in that it is powder or the capsule that is mixed by following former medicine proportioning by weight; The perhaps tablet, the capsule that obtain to boil the mode of putting forward of mixture:
Cortex erythrinae 0.1-0.5 part; Caulis Sargentodoxae 1-2 part; Herb Gynostemmae Pentaphylli 0.5-1.5 part; Radix Notoginseng 1-2 part; Mountain Fructus Tsaoko 0.2-1 part; Folium Mayteni hookeri 0.2-1 part; Rhizoma Paridis 0.1-0.9 part; Purple Radix Codonopsis 1-2 part; Armoracia rusticana (Lam.) P. Gaertner et Sc 1-2 part; Radix Aconiti Kusnezoffii 4-8 part.
2. the Dai nationality according to claim 1 rheumatism medicine among the people is characterized in that in the said ratio scope, the proportioning between flavour of a drug is:
0.3 part of Cortex erythrinae; 1.5 parts of Caulis Sargentodoxae; 1.1 parts of Herb Gynostemmae Pentaphylli; 1.5 parts of Radix Notoginsengs; 0.6 part of mountain Fructus Tsaoko; 0.6 part of Folium Mayteni hookeri; 0.5 part of Rhizoma Paridis; 1.6 parts of purple Radix Codonopsis; 1.2 parts of Armoracia rusticana (Lam.) P. Gaertner et Sc; 6.1 parts of Radix Aconiti Kusnezoffii.
3. according to the described the Dai nationality of one of claim 1-2 rheumatism medicine among the people, it is characterized in that the fineness of powder is not less than 120 orders.
CN2010102925390A 2010-09-20 2010-09-20 Dai nationality medicine for treating rheumatism Expired - Fee Related CN101940700B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102925390A CN101940700B (en) 2010-09-20 2010-09-20 Dai nationality medicine for treating rheumatism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102925390A CN101940700B (en) 2010-09-20 2010-09-20 Dai nationality medicine for treating rheumatism

Publications (2)

Publication Number Publication Date
CN101940700A true CN101940700A (en) 2011-01-12
CN101940700B CN101940700B (en) 2011-12-07

Family

ID=43433029

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102925390A Expired - Fee Related CN101940700B (en) 2010-09-20 2010-09-20 Dai nationality medicine for treating rheumatism

Country Status (1)

Country Link
CN (1) CN101940700B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107080751A (en) * 2017-04-27 2017-08-22 皖西学院 A kind of Western medicine compound for treating hypertrophic osteoarthropathy and its application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1145251A (en) * 1996-09-20 1997-03-19 缪兴财 Pill for removing rheumatism

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1145251A (en) * 1996-09-20 1997-03-19 缪兴财 Pill for removing rheumatism

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《中医杂志》 19881231 磨玉成 中医治疗类风湿性关节炎进展 , 第05期 2 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107080751A (en) * 2017-04-27 2017-08-22 皖西学院 A kind of Western medicine compound for treating hypertrophic osteoarthropathy and its application

Also Published As

Publication number Publication date
CN101940700B (en) 2011-12-07

Similar Documents

Publication Publication Date Title
CN101961443B (en) Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof
CN103690851A (en) Chinese medicinal composition for treating phthisis
CN106309116A (en) Chinese mugwort moxibustion paster and production process thereof
CN100593417C (en) Chinese traditional medicine for treating gastric cancer and bone cancer
CN102847075B (en) Medicine composition for treating insomnia
CN101940700B (en) Dai nationality medicine for treating rheumatism
CN103272159B (en) Chinese herbal preparation used for treating consumptive disease and preparation method thereof
CN102872309A (en) Chinese medicine formulation of climacteric mind tranquilizing drug for treating climacteric syndrome and dysfunction of autonomic nervous system
CN102908396B (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN104825611A (en) Traditional Chinese medicine preparation for treating constipation due to deficiency pf vital energy
CN100525821C (en) Chinese medicine for treating bed-wetting disease and its production
CN102949698A (en) Medicine for treating uterine myoma and preparation method thereof
CN103301283B (en) Traditional Chinese medicine preparation for treating hernia
CN102000181A (en) Chinese traditional medicine composition for treating diarrhea and method for preparing medicament from Chinese traditional medicine composition
CN104288381A (en) Medicinal liquor for treating arthralgia and production method thereof
CN102886017A (en) Traditional Chinese medicine for treating ovarian cyst
CN102068583B (en) Chinese medicinal preparation for treating preceded menstrual cycle due to deficiency of vital energy
CN103585598B (en) Chinese medicinal composition for treating chronic colonitis
CN102973866A (en) Chinese traditional medicine compound navel patch for treating prostate disease
CN100377739C (en) Gynecopathy treating medicine and its prepn process
CN106215070A (en) A kind of Chinese medicine treating infantile enuresis
CN105362596A (en) Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof
CN106266555A (en) A kind of Chinese medicine composition treating few essence, azoospermia
CN101744896B (en) Traditional Chinese medicine for warming and activating meridian, reducing swelling and easing pain and treating osteopathy
CN104840645A (en) Traditional Chinese medicine for treating dizziness

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111207

Termination date: 20140920

EXPY Termination of patent right or utility model